Sonic Healthcare Ltd
ASX:SHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sonic Healthcare Ltd
Cash from Operating Activities
Sonic Healthcare Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cash from Operating Activities
AU$1.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cash from Operating Activities
AU$84.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Rhythm Biosciences Ltd
ASX:RHY
|
Cash from Operating Activities
-AU$6.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cash from Operating Activities
AU$182.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Cash from Operating Activities
AU$17.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Cash from Operating Activities
AU$187.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-4%
|
|
Sonic Healthcare Ltd
Glance View
Sonic Healthcare Ltd. began its journey in 1987, carved from a niche of independent pathology practices in Australia. It swiftly evolved into a global player, embracing a model that combines local expertise with the strength of an international network. The heart of Sonic's operations lies in its robust diagnostic services. Its laboratories process millions of tests each year, ensuring timely and accurate results across a spectrum of medical diagnostics, including pathology, radiology, and general practice medicine. This core service is augmented by state-of-the-art technology and a commitment to quality care, which has earned Sonic a reputation for reliability and excellence in the healthcare sector. Financially, Sonic Healthcare thrives on a business model that capitalizes on high volume and steady demand for medical diagnostic services. The company generates revenue through contracts with hospitals, clinics, and governments, providing essential health services that are non-discretionary and resilient, even in economic downturns. Growth is driven by strategic acquisitions and partnerships, which expand its footprint across regions like North America and Europe, ensuring a stream of diversified income. As healthcare spending continues to rise globally, Sonic Healthcare's business model remains well-positioned to leverage its international presence and expertise in diagnostic excellence, fueling sustainable growth and shareholder value over the long term.
See Also
What is Sonic Healthcare Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.4B
AUD
Based on the financial report for Dec 31, 2025, Sonic Healthcare Ltd's Cash from Operating Activities amounts to 1.4B AUD.
What is Sonic Healthcare Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
9%
Over the last year, the Cash from Operating Activities growth was 10%. The average annual Cash from Operating Activities growth rates for Sonic Healthcare Ltd have been -12% over the past three years , -4% over the past five years , and 9% over the past ten years .